Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts

Yen, Muh–Yong; Schwartz, Jonathan; Chen, Shey-Ying; King, Chwan-Chuen; Yang, Guang-Yang; Hsueh, Po-Ren

doi:10.1016/j.jmii.2020.03.011

Cited by 106 publications

(113 citation statements)

References 12 publications

Supporting

Mentioning

109

Contrasting

Unclassified

Order By: Relevance

“…The hatching period for COVID-19 lasts 2-14 days, but current studies indicate that it can be as long as 21 days [18,26]. The virus is highly infectious, as confirmed by recent epidemiological data.…”

Section: Sars-cov-2 and Covid-19: Epidemiology Pathology And Symptomsmentioning

confidence: 59%

See 1 more Smart Citation

COVID-19 challenge for modern medicine

et al. 2020

View full text Add to dashboard Cite

Coronaviruses cause disease in animals and people around the world. Human coronaviruses (HCoV) are mainly known to cause infections of the upper and lower respiratory tract but the symptoms may also involve the nervous and digestive systems. Since the beginning of December 2019, there has been an epidemic of SARS-CoV-2, which was originally referred to as 2019-nCoV. The most common symptoms are fever and cough, fatigue, sputum production, dyspnea, myalgia, arthralgia or sore throat, headache, nausea, vomiting or diarrhea (30%). The best prevention is to avoid exposure. In addition, contact persons should be subjected to mandatory quarantine. COVID-19 patients should be treated in specialist centers. A significant number of patients with pneumonia require passive oxygen therapy. Non-invasive ventilation and high-flow nasal oxygen therapy can be applied in mild and moderate non-hypercapnia cases. A lung-saving ventilation strategy must be implemented in acute respiratory distress syndrome and mechanically ventilated patients. Extracorporeal membrane oxygenation is a highly specialized method, available only in selected centers and not applicable to a significant number of cases. Specific pharmacological treatment for COVID-19 is not currently available. Modern medicine is gearing up to fight the new coronavirus pandemic. The key is a holistic approach to the patient including, primarily, the use of personal protective equipment to reduce the risk of further virus transmission, as well as patient management, which consists in both quarantine and, in the absence of specific pharmacological therapy, symptomatic treatment. (Cardiol J 2020; 27, 2: 175-183)

show abstract

Section: Sars-cov-2 and Covid-19: Epidemiology Pathology And Symptomsmentioning

confidence: 59%

“…However, in many situations, the emergency medical service staff perform interventions where they may suspect a coronavirus infection only on the basis of an examination and interview. Then, after transport, the ambulance should be disinfected with disinfectants with a wide range of viricidal effects [26].…”

Section: Covid-19 Suspicion Proceduresmentioning

confidence: 99%

COVID-19 challenge for modern medicine

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Non-urgent appointments should be postponed where there is capacity to reschedule within a reasonable time period. Consistency in the management and use of PPE throughout the patient journey is essential [15]; patients should wear a mask at all times to reduce the potential transmission of COVID-19 to healthcare staff or other patients [16].…”

Section: General Guidancementioning

confidence: 99%

Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic

Korobelnik

Loewenstein

Eldem

et al. 2020

Graefes Arch Clin Exp Ophthalmol

108

166

View full text Add to dashboard Cite

Purpose There is an urgent need to address how to best provide ophthalmic care for patients with retinal disease receiving intravitreal injections with anti-vascular endothelial growth factor agents during the ongoing global COVID-19 pandemic. This article provides guidance for ophthalmologists on how to deliver the best possible care for patients while minimizing the risk of infection. Methods The Vision Academy's Steering Committee of international retinal disease experts convened to discuss key considerations for managing patients with retinal disease during the COVID-19 pandemic. After reviewing the existing literature on the issue, members put forward recommendations that were systematically refined and voted on to develop this guidance. Results The considerations focus on the implementation of steps to minimize the exposure of patients and healthcare staff to COVID-19. These include the use of personal protective equipment, adherence to scrupulous hygiene and disinfection protocols, pre-screening to identify symptomatic patients, and reducing the number of people in waiting rooms. Other important measures include triaging of patients to identify those at the greatest risk of irreversible vision loss and prioritization of treatment visits over monitoring visits where possible. In order to limit patient exposure, ophthalmologists should refrain from using treatment regimens that require frequent monitoring. Conclusion Management of patients with retinal disease receiving intravitreal injections during the COVID-19 pandemic will require adjustment to regular clinical practice to minimize the risk of exposure of patients and healthcare staff, and to prioritize those with the greatest medical need. The safety of patients and healthcare staff should be of paramount importance in all decision-making.

show abstract

“…5 However, the successful control programs for COVID-19 infection in Taiwan are promising and it may resulted from the experience of managing the outbreak of Severe Acute Response Syndrome(SARS) in Taiwan, 2003. 6,7 Initially, government of Taiwan took several rapid responses since January to prevent the COVID-19 outbreak crisis, such as border control from the air and sea, case identification, quarantine of suspicious cases, holiday extension, travel restriction and so on. 8 In addition, the government decided to prohibit the export of surgical masks to make sure masks were not too short and started to manufacture masks.…”

Section: Perspectivesmentioning

confidence: 99%

The preventive strategies of community hospital in the battle of fighting pandemic COVID-19 in Taiwan

Yang¹,

Chen²,

Chen³

2020

Journal of Microbiology, Immunology and Infection

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract

Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts

Cited by 106 publications

References 12 publications

COVID-19 challenge for modern medicine

COVID-19 challenge for modern medicine

Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic

The preventive strategies of community hospital in the battle of fighting pandemic COVID-19 in Taiwan

Contact Info

Product

Resources

About